206 related articles for article (PubMed ID: 18566690)
41. Impact of Phytochemicals on PPAR Receptors: Implications for Disease Treatments.
Enayati A; Ghojoghnejad M; Roufogalis BD; Maollem SA; Sahebkar A
PPAR Res; 2022; 2022():4714914. PubMed ID: 36092543
[TBL] [Abstract][Full Text] [Related]
42. The Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Pan-Cancer.
Huang R; Zhang J; Li M; Yan P; Yin H; Zhai S; Zhu X; Hu P; Zhang J; Huang L; Li M; Sun Z; Meng T; Yang D; Huang Z
PPAR Res; 2020; 2020():6527564. PubMed ID: 33029111
[TBL] [Abstract][Full Text] [Related]
43. Design, synthesis and evaluation of substituted phenylpropanoic acid derivatives as peroxisome proliferator-activated receptor (PPAR) activators: novel human PPARalpha-selective activators.
Miyachi H; Nomura M; Tanase T; Takahashi Y; Ide T; Tsunoda M; Murakami K; Awano K
Bioorg Med Chem Lett; 2002 Jan; 12(1):77-80. PubMed ID: 11738577
[TBL] [Abstract][Full Text] [Related]
44. Peroxisome proliferator-activated receptors and inflammation.
Moraes LA; Piqueras L; Bishop-Bailey D
Pharmacol Ther; 2006 Jun; 110(3):371-85. PubMed ID: 16168490
[TBL] [Abstract][Full Text] [Related]
45. Nuclear receptors of the peroxisome proliferator-activated receptor (PPAR) family in gestational diabetes: from animal models to clinical trials.
Arck P; Toth B; Pestka A; Jeschke U
Biol Reprod; 2010 Aug; 83(2):168-76. PubMed ID: 20427759
[TBL] [Abstract][Full Text] [Related]
46. Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels.
Yessoufou A; Wahli W
Swiss Med Wkly; 2010; 140():w13071. PubMed ID: 20842602
[TBL] [Abstract][Full Text] [Related]
47. Peroxisome proliferator activated receptor-gamma ligands as potent antineoplastic agents.
Theocharisa S; Margeli A; Kouraklis G
Curr Med Chem Anticancer Agents; 2003 May; 3(3):239-51. PubMed ID: 12769781
[TBL] [Abstract][Full Text] [Related]
48. Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons.
Tenenbaum A; Motro M; Fisman EZ
Cardiovasc Diabetol; 2005 Sep; 4():14. PubMed ID: 16168052
[TBL] [Abstract][Full Text] [Related]
49. Structural development studies of PPARs ligands based on tyrosine scaffold.
De Filippis B; Linciano P; Ammazzalorso A; Di Giovanni C; Fantacuzzi M; Giampietro L; Laghezza A; Maccallini C; Tortorella P; Lavecchia A; Loiodice F; Amoroso R
Eur J Med Chem; 2015 Jan; 89():817-25. PubMed ID: 25462281
[TBL] [Abstract][Full Text] [Related]
50. The Role of PPARs in Disease.
Wagner N; Wagner KD
Cells; 2020 Oct; 9(11):. PubMed ID: 33126411
[TBL] [Abstract][Full Text] [Related]
51. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression.
Schoonjans K; Staels B; Auwerx J
J Lipid Res; 1996 May; 37(5):907-25. PubMed ID: 8725145
[TBL] [Abstract][Full Text] [Related]
52. Peroxisome proliferator-activated receptors, coactivators, and downstream targets.
Qi C; Zhu Y; Reddy JK
Cell Biochem Biophys; 2000; 32 Spring():187-204. PubMed ID: 11330046
[TBL] [Abstract][Full Text] [Related]
53. Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?
Scatena R; Bottoni P; Giardina B
PPAR Res; 2008; 2008():256251. PubMed ID: 18645611
[TBL] [Abstract][Full Text] [Related]
54. PPAR modulators and PPAR pan agonists for metabolic diseases: the next generation of drugs targeting peroxisome proliferator-activated receptors?
Feldman PL; Lambert MH; Henke BR
Curr Top Med Chem; 2008; 8(9):728-49. PubMed ID: 18537685
[TBL] [Abstract][Full Text] [Related]
55. An overview on biological mechanisms of PPARs.
Kota BP; Huang TH; Roufogalis BD
Pharmacol Res; 2005 Feb; 51(2):85-94. PubMed ID: 15629253
[TBL] [Abstract][Full Text] [Related]
56. Peroxisome proliferator-activated receptors and the metabolic syndrome.
Bragt MC; Popeijus HE
Physiol Behav; 2008 May; 94(2):187-97. PubMed ID: 18191967
[TBL] [Abstract][Full Text] [Related]
57. PPARs and Myocardial Infarction.
Wagner KD; Wagner N
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322384
[TBL] [Abstract][Full Text] [Related]
58. Control of peroxisome proliferator-activated receptor fate by the ubiquitinproteasome system.
Genini D; Catapano CV
J Recept Signal Transduct Res; 2006; 26(5-6):679-92. PubMed ID: 17118805
[TBL] [Abstract][Full Text] [Related]
59. [PPAR receptors: recent data].
Vidal H
Ann Endocrinol (Paris); 2005 Apr; 66(2 Pt 2):1S5-9. PubMed ID: 15959399
[TBL] [Abstract][Full Text] [Related]
60. SAR-oriented discovery of peroxisome proliferator-activated receptor pan agonist with a 4-adamantylphenyl group as a hydrophobic tail.
Kasuga J; Yamasaki D; Ogura K; Shimizu M; Sato M; Makishima M; Doi T; Hashimoto Y; Miyachi H
Bioorg Med Chem Lett; 2008 Feb; 18(3):1110-5. PubMed ID: 18162399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
